U.S. flag

An official website of the United States government

NC_000001.10:g.(?_145507647)_(145509231_?)del AND Radial aplasia-thrombocytopenia syndrome

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Dec 23, 2019
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000633531.4

Allele description [Variation Report for NC_000001.10:g.(?_145507647)_(145509231_?)del]

NC_000001.10:g.(?_145507647)_(145509231_?)del

Gene:
RBM8A:RNA binding motif protein 8A [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
1q21.1
Genomic location:
Chr1: 145507647 - 145509231 (on Assembly GRCh37)
Preferred name:
NC_000001.10:g.(?_145507647)_(145509231_?)del
HGVS:
NC_000001.10:g.(?_145507647)_(145509231_?)del

Condition(s)

Name:
Radial aplasia-thrombocytopenia syndrome (TAR)
Synonyms:
Absent radii and thrombocytopenia; Thrombocytopenia absent radii; TAR syndrome; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0010121; MeSH: C536940; MedGen: C0175703; Orphanet: 3320; OMIM: 274000

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000754777Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Dec 23, 2019)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Complex inheritance pattern resembling autosomal recessive inheritance involving a microdeletion in thrombocytopenia-absent radius syndrome.

Klopocki E, Schulze H, Strauss G, Ott CE, Hall J, Trotier F, Fleischhauer S, Greenhalgh L, Newbury-Ecob RA, Neumann LM, Habenicht R, König R, Seemanova E, Megarbane A, Ropers HH, Ullmann R, Horn D, Mundlos S.

Am J Hum Genet. 2007 Feb;80(2):232-40. Epub 2006 Dec 21.

PubMed [citation]
PMID:
17236129
PMCID:
PMC1785342

Clinical utility of array comparative genomic hybridisation in prenatal setting.

Lovrecic L, Remec ZI, Volk M, Rudolf G, Writzl K, Peterlin B.

BMC Med Genet. 2016 Nov 15;17(1):81.

PubMed [citation]
PMID:
27846804
PMCID:
PMC5111187
See all PubMed Citations (4)

Details of each submission

From Invitae, SCV000754777.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

A gross deletion of the genomic region encompassing the full coding sequence of the RBM8A gene has been identified. The boundaries of this event are unknown as the deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. Gross deletions of the entire RBM8A gene are included in the critical region of a recurrent microdeletion that spans chromosomal band 1q21.1 and includes additional genes. This microdeletion has been reported in many individuals affected with thrombocytopenia-absent radius (TAR) syndrome and is typically inherited along with an additional hypomorphic variant on the opposite allele (PMID: 17236129, 24220582, 27846804). Loss-of-function variants in RBM8A are known to be pathogenic (PMID: 22366785). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 23, 2022